PetIQ Inc is primarily active in the pet health and wellness industry.

The main competitors of PetIQ Inc in the market include companies such as Zoetis Inc, IDEXX Laboratories, and Elanco Animal Health.

PetIQ Inc is a leading pet health and wellness company, specializing in accessible and affordable veterinary services. Established in 2010, PetIQ has swiftly grown into a prominent player in the pet care industry. The company operates a national network of veterinary clinics and offers an extensive array of pet medications and health products. With a dedication to providing high-quality care at affordable prices, PetIQ has gained a strong reputation among pet owners. Their commitment to pets' well-being has positioned PetIQ as a trusted name in the industry.

Some significant milestones that PetIQ Inc, a leading pet health and wellness company, has achieved include successfully expanding its product portfolio to offer various pet medications, veterinary services, and wellness products. PetIQ has also established partnerships with major retailers, enabling them to reach a wider customer base. The company has experienced substantial revenue growth and successfully conducted an initial public offering (IPO) in 2017. In addition, PetIQ has focused on enhancing its e-commerce capabilities, providing convenient online shopping for pet owners. Overall, PetIQ Inc has made significant strides in becoming a prominent player in the pet care industry.

PetIQ Inc is primarily present in the United States. With its headquarters based in Eagle, Idaho, the company operates nationwide, providing essential pet health and wellness products and services. PetIQ Inc serves pet owners and veterinary clinics across all states in the US, offering a comprehensive range of veterinarian-grade pet medications, over-the-counter flea and tick control products, and other pet supplies. With a strong focus on making pet care more accessible and affordable, PetIQ Inc has established a significant presence in the US market, catering to the needs of pet owners and their furry companions throughout the country.

PetIQ Inc represents a strong commitment to providing affordable, accessible, and high-quality pet healthcare products and services. With a focus on pet wellness, their corporate philosophy revolves around enhancing the bond between pets and their owners by offering convenient solutions and expert advice. PetIQ Inc strives to make pet healthcare accessible to all through their comprehensive range of over-the-counter products, prescription medications, and veterinary services. By prioritizing affordability without compromising on quality, they aim to improve the overall well-being of pets and contribute positively to their customers' lives. PetIQ Inc's dedication to pet health and their customer-centered approach makes them a trusted and reliable choice for pet owners.

Analysts currently set an average price target of 31,11 USD for the PetIQ stock (median: 31,11 USD), implying +0,4 % versus the latest price. The consensus is based on 11 analyst ratings.

PetIQ Analyytikkojen kursstavoitteet 2026

11 analysts currently rate the PetIQ stock: 7 recommend buying, 4 holding and 0 selling. For 2026, analysts expect PetIQ to generate revenue of 1,31 Mrd. USD and earnings per share of 1,86 USD.

PetIQ Analyytikkojen kursstavoitteet 2026

Converted at the current exchange rate, the PetIQ share trades at 26,86 EUR (30,98 USD).

The PetIQ share (PETQ) is listed on 4 stock exchanges, including: NASDAQ (PETQ), Frankfurt (39L.F), München (39L.MU), Düsseldorf (39L.DU).

PetIQ Inc is a company based in Idaho, USA, specializing in the sale of animal health products and veterinary services. The company operates in three main business areas: retail, prescription medications, and services. In the retail sector, PetIQ Inc offers a wide range of animal health products, including supplements, food and water bowls, pet care products, toys, and treats. These products are sold in various retail outlets, including discount stores, pet supply stores, and online platforms. The company also owns two retail brands, VIP Petcare and VetIQ, which also operate in the USA. The prescription medications sector is another important business area for PetIQ. The company distributes prescription medications for pets, such as antibiotics, painkillers, and anti-parasite medications. These medications are sold through veterinary practices and the company's online shop. PetIQ also has its own brand of prescription medications called PetArmor. Services such as veterinary consultations, vaccinations, and diagnostics are another important branch of PetIQ Inc's business. The company operates mobile veterinary services, which are available in many US states, including VIP Petcare clinics, which are now operating in select Walmart locations. The company follows a growth model through strategic acquisitions to expand its product offering and market presence. An example of this is the acquisition of PetArmor in 2018. Another important aspect of PetIQ's business model is establishing a strong presence in the e-commerce sector through online sales of animal health products and prescription medications. These online sales platforms have experienced rapid growth in recent years, as they provide customers with a convenient way to purchase pet products. PetIQ also has a presence on social media platforms such as Facebook and Twitter to promote its products and services and engage with customers. The company also utilizes various marketing strategies such as promotions, discounts, and seasonal sales to encourage customer loyalty and stimulate customer purchasing behavior. Overall, PetIQ Inc has developed an innovative and diverse business model that allows it to offer a wide range of animal health products and services. The company has established itself as a significant player, providing innovative and affordable solutions for pet owners worldwide to keep their pets healthy. And, importantly, the pet business has gained even more momentum during a global pandemic.

odotettu liikevaihto PetIQ on 1,31 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto PetIQ on 54,42 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

PetIQ:n hinta-voitto-suhde (P/E) on tällä hetkellä 16,62. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan PetIQ-osakkeen arvostusta.

PetIQ:n hinta-myynti-suhde (P/S) on tällä hetkellä 0,69. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii PetIQ-osakkeen arvostuskennuslukuna.

PetIQ:n Eulpool-laatuscore on 3/10.

PetIQ:n ISIN on US71639T1060. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

PetIQ:n WKN on A2DU79. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

PetIQ:n ticker on PETQ. Tämä pörssinoteeraus käytetään PetIQ-osakkeiden kauppaan pörssissä.

PetIQ maksoi osinkoa joka vuosi viimeisten 0 vuoden aikana.

PetIQ kuuluu sektoriin 'Terveydenhuolto'.

PetIQ:n osingot jaetaan valuutassa USD.